Jordi Félez

2.0k total citations
57 papers, 1.7k citations indexed

About

Jordi Félez is a scholar working on Hematology, Cancer Research and Molecular Biology. According to data from OpenAlex, Jordi Félez has authored 57 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 26 papers in Cancer Research and 17 papers in Molecular Biology. Recurrent topics in Jordi Félez's work include Blood Coagulation and Thrombosis Mechanisms (26 papers), Protease and Inhibitor Mechanisms (26 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers). Jordi Félez is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (26 papers), Protease and Inhibitor Mechanisms (26 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (7 papers). Jordi Félez collaborates with scholars based in Spain, United States and Belgium. Jordi Félez's co-authors include Lindsey A. Miles, Edward F. Plow, Janet Plescia, Carol Dahlberg, Pere Fábregas, Mercè Jardı́, Colin Longstaff, Pura Muñoz‐Cánoves, EF Plow and Francesc Miralles and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Cell Biology.

In The Last Decade

Jordi Félez

55 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jordi Félez Spain 21 875 784 640 235 191 57 1.7k
Roger Lijnen Belgium 16 918 1.0× 500 0.6× 619 1.0× 203 0.9× 196 1.0× 72 1.8k
Jos Grimbergen Netherlands 29 430 0.5× 1.0k 1.3× 459 0.7× 183 0.8× 448 2.3× 52 2.5k
B. Van Hoef Belgium 34 1.5k 1.7× 851 1.1× 915 1.4× 177 0.8× 339 1.8× 70 2.7k
G.A. Grant United States 12 982 1.1× 597 0.8× 399 0.6× 278 1.2× 511 2.7× 12 1.7k
Harry Veerman Netherlands 11 847 1.0× 423 0.5× 644 1.0× 152 0.6× 80 0.4× 14 1.3k
K E Langley United States 19 748 0.9× 854 1.1× 574 0.9× 394 1.7× 732 3.8× 21 2.3k
P Bourdon United States 13 444 0.5× 533 0.7× 401 0.6× 94 0.4× 180 0.9× 14 1.6k
Peter A. Jones United States 16 494 0.6× 1.2k 1.5× 111 0.2× 125 0.5× 283 1.5× 32 1.9k
Richard J. Fish Switzerland 21 255 0.3× 586 0.7× 230 0.4× 108 0.5× 106 0.6× 51 1.5k
José A. Urı́a Spain 13 715 0.8× 487 0.6× 195 0.3× 179 0.8× 477 2.5× 14 1.2k

Countries citing papers authored by Jordi Félez

Since Specialization
Citations

This map shows the geographic impact of Jordi Félez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Félez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Félez more than expected).

Fields of papers citing papers by Jordi Félez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordi Félez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Félez. The network helps show where Jordi Félez may publish in the future.

Co-authorship network of co-authors of Jordi Félez

This figure shows the co-authorship network connecting the top 25 collaborators of Jordi Félez. A scholar is included among the top collaborators of Jordi Félez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordi Félez. Jordi Félez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baiget, Montserrat, et al.. (2014). Assessment of primary healthcare professionals’ management of hypertensive patients with riser pattern. European Journal of Cardiovascular Nursing. 14(1). 73–78. 1 indexed citations
2.
Planas, Lourdes G., et al.. (2013). Nurse-Driven Training Courses: Impact on Implementation of Ambulatory Blood Pressure Monitoring. The Open Nursing Journal. 7(1). 35–40. 1 indexed citations
3.
Altés, Albert, Vanessa Bach, Anna Esteve‐Codina, et al.. (2009). Mutations in HAMP and HJV genes and their impact on expression of clinical hemochromatosis in a cohort of 100 Spanish patients homozygous for the C282Y mutation of HFE gene. Annals of Hematology. 88(10). 951–955. 15 indexed citations
4.
Altés, Albert, Vanessa Bach, Anna Esteve‐Codina, et al.. (2008). Does the SLC40A1 gene modify HFE-related haemochromatosis phenotypes?. Annals of Hematology. 88(4). 341–345. 14 indexed citations
5.
Remacha, Ángel F., Eugenio Berlanga, Assumpta Caixàs, et al.. (2008). Serum soluble transferrin receptor concentrations are increased in central obesity. Results from a screening programme for hereditary hemochromatosis in men with hyperferritinemia. Clinica Chimica Acta. 400(1-2). 111–116. 28 indexed citations
6.
Gong, Yun Yun, et al.. (2001). Conversion of Glu-Plasminogen to Lys-Plasminogen Is Necessary for Optimal Stimulation of Plasminogen Activation on the Endothelial Cell Surface. Journal of Biological Chemistry. 276(22). 19078–19083. 58 indexed citations
7.
Maeyer, Marc De, et al.. (2001). Critical role of glutamic acid 202 in the enzymatic activity of stromelysin‐1 (MMP‐3). European Journal of Biochemistry. 268(3). 826–831. 18 indexed citations
8.
Hoylaerts, Marc, et al.. (2000). Prostromelysin‐1 (proMMP‐3) stimulates plasminogen activation by tissue‐type plasminogen activator. European Journal of Biochemistry. 267(21). 6378–6384. 13 indexed citations
9.
Miralles, Francesc, Dina Ron, Montserrat Baiget, Jordi Félez, & Pura Muñoz‐Cánoves. (1998). Differential Regulation of Urokinase-type Plasminogen Activator Expression by Basic Fibroblast Growth Factor and Serum in Myogenesis. Journal of Biological Chemistry. 273(4). 2052–2058. 28 indexed citations
10.
López-Pedrera, C., Mercè Jardı́, Julia Inglés‐Esteve, et al.. (1997). Characterization of tissue factor expression on the human endothelial cell line ECV304. American Journal of Hematology. 56(2). 71–78. 18 indexed citations
11.
Declerck, Paul, I. Juhan‐Vague, Jordi Félez, & B. Wiman. (1994). Pathophysiology of fibrinolysis. Journal of Internal Medicine. 236(4). 425–432. 35 indexed citations
12.
Félez, Jordi, et al.. (1993). RECEPTOR OCCUPANCY BY PLASMINOGEN ENHANCES ITS ACTIVATION BY TPA. Thrombosis and Haemostasis. 69(6). 1232–1232. 5 indexed citations
13.
Miles, Lindsey A., et al.. (1991). Role of cell-surface lysines in plasminogen binding to cells: identification of .alpha.-enolase as a candidate plasminogen receptor. Biochemistry. 30(6). 1682–1691. 478 indexed citations
14.
Félez, Jordi, et al.. (1991). Binding of tissue plasminogen activator to human monocytes and monocytoid cells. Blood. 78(9). 2318–2327. 44 indexed citations
15.
Grau, E, et al.. (1990). [Intracranial hemorrhage in patients undergoing anticoagulant treatment with acenocoumarol].. PubMed. 94(6). 201–3. 1 indexed citations
16.
Félez, Jordi. (1990). Biochemical aspects of the pathogenesis of venous thrombosis.. PubMed. 556. 9–17. 2 indexed citations
17.
Fontcuberta, J., et al.. (1988). Quantitative and qualitative congenital deficiency of antithrombin III: A new molecular variant called at III - Barcelona 2. Thrombosis Research. 51(1). 75–81. 4 indexed citations
18.
Sala, Núria, M. Borrell, Kenneth A. Bauer, et al.. (1987). Dysfunctional Activated Protein C (PC Cádiz) in a Patient with Thrombotic Disease. Thrombosis and Haemostasis. 57(2). 183–186. 14 indexed citations
19.
Grau, E, et al.. (1985). Thrombopénie sévère précoce induite par l'héparine non fractionnée: tentative thérapeutique par une héparine de bas poids moléculaire.. 27(6). 1 indexed citations
20.
Borrell, M., et al.. (1982). [Changes in fibrinolysis in liver cirrhosis].. PubMed. 27(4-B). 727–36. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roger Lijnen Breakdown of academic impact, for papers by Jos Grimbergen Breakdown of academic impact, for papers by B. Van Hoef Breakdown of academic impact, for papers by G.A. Grant Breakdown of academic impact, for papers by Harry Veerman Breakdown of academic impact, for papers by K E Langley Breakdown of academic impact, for papers by P Bourdon Breakdown of academic impact, for papers by Peter A. Jones Breakdown of academic impact, for papers by Richard J. Fish Breakdown of academic impact, for papers by José A. Urı́a
Rankless by CCL
2026